Generic Ativan Manufacturers

By Peter Brennan

Maine legislators are Generic Ativan Manufacturers scheduled to hold a hearing Thursday on an ambitious piece of offshore wind legislation proposed by Gov. John Baldacci.

Under the Generic Ativan Manufacturers legislation, the state would set a target of 300 megawatts (MW) of installed offshore wind capacity by 2020 and Generic Ativan Manufacturers 5,000 MW of installed offshore wind capacity by 2030.  The legislation also includes a Generic Ativan Manufacturers goal of 3,000 MW of overall wind energy capacity in the Generic Ativan Manufacturers state by 2020 and 8,000 MW by 2030.

The bill, An Act To Implement the Recommendations of the Governor’s Ocean Energy Task Force (L.D. 1810), is Generic Ativan Manufacturers scheduled for a public hearing before the Utilities and Energy Committee on Thursday, March 11 at 1PM.

The legislation would create leasing procedures that Generic Ativan Manufacturers allow phased development and discourage speculative site banking.  Additionally, the Generic Ativan Manufacturers bill would form a Renewable Ocean Energy Trust Fund for Generic Ativan Manufacturers lease fees generated by renewable ocean energy projects and make that Generic Ativan Manufacturers money available for research, resource enhancement and compensation to help mitigate adverse impacts caused by development.

The legislation also calls for Generic Ativan Manufacturers the development of tidal energy resources in Maine’s coastal waters.

The legislation has Generic Ativan Manufacturers already attracted opposition from Gulf of Maine fishermen and other citizen groups.  In February, the Citizens’ Task Force on Wind Power asked Baldacci to Generic Ativan Manufacturers issue an executive order putting all of the state’s new wind projects on hold, citing concerns about potential negative impacts on public health and Generic Ativan Manufacturers the environment.